Anticholinergic medication for antipsychotic-induced tardive dyskinesia.

Author: BergmanHanna, Soares-WeiserKarla

Paper Details 
Original Abstract of the Article :
Antipsychotic (neuroleptic) medication is used extensively to treat people with serious mental illnesses. However, it is associated with a wide range of adverse effects, including movement disorders. Because of this, many people treated with antipsychotic medication also receive anticholinergic drug...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491293/

データ提供:米国国立医学図書館(NLM)

Anticholinergics: A Delicate Dance in Treating Tardive Dyskinesia

Tardive dyskinesia, a movement disorder often associated with antipsychotic medications, can be a challenging condition to manage. Imagine a desert traveler, experiencing involuntary movements, making it difficult to navigate their journey. This research explores the potential role of anticholinergic medications in treating tardive dyskinesia, examining the intricate balance between benefits and potential risks.

Anticholinergics: A Complex Relationship with Tardive Dyskinesia

Anticholinergics, a type of medication often used to reduce movement side effects associated with antipsychotic drugs, are a subject of ongoing research. It's like a desert oasis with hidden currents, offering potential relief but also carrying uncertainties. This research highlights the conflicting findings from animal studies, suggesting a potential link between chronic anticholinergic use and tardive dyskinesia. It's a reminder that even seemingly beneficial interventions can have unexpected consequences.

Navigating the Use of Anticholinergics

The research emphasizes the importance of careful consideration and monitoring when using anticholinergics to manage tardive dyskinesia. It's like a desert traveler cautiously navigating a complex landscape, aware of potential dangers. The authors encourage further research to better understand the long-term effects of anticholinergics and develop more targeted and effective treatment approaches.

Dr.Camel's Conclusion

This research reminds us that navigating the complexities of tardive dyskinesia treatment requires a delicate balance between alleviating symptoms and minimizing potential risks. Like a skilled desert guide, we must carefully consider the potential benefits and risks of anticholinergic medications, ensuring we make informed decisions for the well-being of our patients.

Date :
  1. Date Completed 2018-03-01
  2. Date Revised 2022-03-17
Further Info :

Pubmed ID

29341071

DOI: Digital Object Identifier

PMC6491293

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.